{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:21Z","timestamp":1791425361399,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/sj.bjc.6603951","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T15:55:41Z","timestamp":1188316541000},"page":"769-777","source":"Crossref","is-referenced-by-count":56,"title":["Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia"],"prefix":"10.1038","volume":"97","author":[{"given":"A","family":"Olsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Norberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"\u00f6kvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Derkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Celsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"\u00f6sterborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rosenquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,28]]},"reference":[{"key":"BF6603951_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3","volume":"69","author":"M Aguilar-Santelises","year":"1996","unstructured":"Aguilar-Santelises M, Rottenberg ME, Lewin N, Mellstedt H, Jondal M (1996) Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. Int J Cancer 69: 114\u2013119","journal-title":"Int J Cancer"},{"key":"BF6603951_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1600-0609.2004.00334.x","volume":"73","author":"A \u00c5leskog","year":"2004","unstructured":"\u00c5leskog A, Tobin G, Laurell A, Thunberg U, Lindhagen E, Roos G, Nilsson K, Nygren P, Sundstrom C, Hoglund M, Larsson R, Rosenquist R (2004) VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. Eur J Haematol 73: 407\u2013411","journal-title":"Eur J Haematol"},{"key":"BF6603951_CR3","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood.V98.10.3050","volume":"98","author":"A Bernal","year":"2001","unstructured":"Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC, Schattner EJ (2001) Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98: 3050\u20133057","journal-title":"Blood"},{"key":"BF6603951_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DCS (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393\u2013403","journal-title":"Mol Cell"},{"key":"BF6603951_CR5","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennet JM, Grevre M, Kay N, Keating MJ, O'Brien S, Rai KR (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990\u20134997","journal-title":"Blood"},{"key":"BF6603951_CR6","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu C, Kipps TJ, Negrini M, Croce CM (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. PNAS 102: 13944\u201313949","journal-title":"PNAS"},{"key":"BF6603951_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/cimm.2000.1616","volume":"200","author":"A Craxton","year":"2000","unstructured":"Craxton A, Chuang PI, Shu G, Harlan JM, Clark EA (2000) The CD40-inducible Bcl-2 family member A1 protects B cells form antigen receptor-mediated apoptosis. Cell Immunol 200: 56\u201362","journal-title":"Cell Immunol"},{"key":"BF6603951_CR8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N (1999) IgVH gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840\u20131847","journal-title":"Blood"},{"key":"BF6603951_CR9","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L, D\u00f6hner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910\u20131916","journal-title":"N Engl J Med"},{"key":"BF6603951_CR10","first-page":"3879","volume":"56","author":"C D'Sa-Eipper","year":"1996","unstructured":"D'Sa-Eipper C, Subramanian T, Chinnadurai G (1996) bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res 56: 3879\u20133882","journal-title":"Cancer Res"},{"key":"BF6603951_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0268-960X(97)90007-2","volume":"11","author":"TJ Hamblin","year":"1997","unstructured":"Hamblin TJ, Oscier DG (1997) Chronic lymphocytic leukaemia: the nature of the leukaemic cell. Blood Rev 11: 71\u201373","journal-title":"Blood Rev"},{"key":"BF6603951_CR12","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94: 1848\u20131854","journal-title":"Blood"},{"key":"BF6603951_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/sj.leu.2404167","volume":"20","author":"R Horie","year":"2006","unstructured":"Horie R, Watanable M, Okamura T, Taira M, Shoda M, Motoji T, Utsunomiya A, Watanable T, Higashihara M, Umezawa K (2006) DHMEQ, a new NF-\u03baB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukaemia cells. Leukemia 20: 800\u2013806","journal-title":"Leukemia"},{"key":"BF6603951_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.leu.2403694","volume":"19","author":"B Jahrsd\u00f6rfer","year":"2005","unstructured":"Jahrsd\u00f6rfer B, Wooldridge JE, Blackwell SE, Taylor CM, Link BK, Weiner GJ (2005) Good prognosis cytogenetics in B-cell chronic lymphocytic leukaemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity. Leukaemia 19: 759\u2013766","journal-title":"Leukaemia"},{"key":"BF6603951_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/10428199709050881","volume":"26","author":"JB Johnston","year":"1997","unstructured":"Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A (1997) P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma 26: 349\u2013435","journal-title":"Leuk Lymphoma"},{"key":"BF6603951_CR16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1080\/10428190410001723317","volume":"45","author":"JB Johnston","year":"2004","unstructured":"Johnston JB, Paul JT, Neufeld NJ, Haney N, Kropp DM, Hu X, Cheang M, Gibson SB (2004) Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. Leuk Lymphoma 45: 2017\u20132027","journal-title":"Leuk Lymphoma"},{"key":"BF6603951_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0046-8177(98)90282-9","volume":"29","author":"H Jung-Ha","year":"1998","unstructured":"Jung-Ha H, Kim D, Lee SB, Hong SI, Park SY, Huh J, Kim CW, Kim SS, Lee Y, Choi SS, Shin HS (1998) Expression of Bfl-1 in normal and tumor tissues: Bfl-1 overexpression in cancer is attributable to its preferential expression in infiltrating inflammatory cells. Hum Pathol 29: 723\u2013728","journal-title":"Hum Pathol"},{"key":"BF6603951_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1040-8428(97)10008-7","volume":"27","author":"J Jurlander","year":"1997","unstructured":"Jurlander J (1997) The cellular biology of B-cell chronic lymphocytic leukemia. Crit Rev Onc Hematol 27: 29\u201352","journal-title":"Crit Rev Onc Hematol"},{"key":"BF6603951_CR19","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1182\/blood.V87.8.3089.bloodjournal8783089","volume":"87","author":"A Karsan","year":"1996","unstructured":"Karsan A, Yee E, Kaushansky K, Harlan JM (1996) Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089\u20133096","journal-title":"Blood"},{"key":"BF6603951_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2004.05225.x","volume":"127","author":"AP Kater","year":"2004","unstructured":"Kater AP, Evers LM, Remmerswaal EB, Jaspers A, Oosterwijk MF, van Lier RA, van Oers MH, Eldering E (2004) CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack. Br J Haematol 127: 404\u2013415","journal-title":"Br J Haematol"},{"key":"BF6603951_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2004.02.021","volume":"212","author":"JK Kim","year":"2004","unstructured":"Kim JK, Kim KD, Lee E, Lim JS, Cho HJ, Yoon HK, Cho MY, Baek KE, Park YP, Paik SG, Choe YK, Lee HG (2004) Up-regulation of Bfl-1\/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line. Cancer Lett 212: 61\u201370","journal-title":"Cancer Lett"},{"key":"BF6603951_CR22","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","volume":"91","author":"S Kitada","year":"1998","unstructured":"Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vivo and in vitro chemoresponses. Blood 91: 3379\u20133389","journal-title":"Blood"},{"key":"BF6603951_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.bjc.6600025","volume":"86","author":"A Kruczynski","year":"2002","unstructured":"Kruczynski A, Eti\u00e9vant C, Perrin D, Chansard N, Duflos A, Hill BT (2002) Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development. Br J Cancer 86: 143\u2013150","journal-title":"Br J Cancer"},{"key":"BF6603951_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/sj.cdd.4401684","volume":"12","author":"JF Kucharczak","year":"2005","unstructured":"Kucharczak JF, Simmons MJ, Duckett CS, Gelinas C (2005) Constitutive proteasome-mediated turnover of Bfl-1\/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor. Cell Death Differ 12: 1225\u20131239","journal-title":"Cell Death Differ"},{"key":"BF6603951_CR25","first-page":"230","volume":"143","author":"R Kuppers","year":"1993","unstructured":"Kuppers R, Zhao M, Rajevsky K, Hansmann ML (1993) Detection of clonal B cell population in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol 143: 230\u2013239","journal-title":"Am J Pathol"},{"key":"BF6603951_CR26","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R","volume":"29","author":"AW Kuss","year":"1999","unstructured":"Kuss AW, Knodel M, Berberich-Siebelt F, Lindemann D, Schimpl A, Berberich I (1999) A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol 29: 3077\u20133088","journal-title":"Eur J Immunol"},{"key":"BF6603951_CR27","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.4049\/jimmunol.156.7.2624","volume":"156","author":"DJ McConkey","year":"1996","unstructured":"McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating M (1996) Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 156: 2624\u20132630","journal-title":"J Immunol"},{"key":"BF6603951_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ijc.20614","volume":"113","author":"AA Morales","year":"2005","unstructured":"Morales AA, Olsson A, Celsing F, sterborg A, Jondal M, Osorio LM (2005) High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. Int J Cancer 113: 730\u2013737","journal-title":"Int J Cancer"},{"key":"BF6603951_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.leu.2400719","volume":"11","author":"JS Moreb","year":"1997","unstructured":"Moreb JS, Schweder M (1997) Human A1, a bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors. Leukemia 11: 998\u20131004","journal-title":"Leukemia"},{"key":"BF6603951_CR30","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1200\/JCO.2005.02.4364","volume":"23","author":"SM O'Brien","year":"2005","unstructured":"O'Brien SM, Cunningham CC, Golenkov AK, Turkina AG, Novick SC, Rai KR (2005) Phase I to II multicenter study of Oblimersen Sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukaemia. J Clin Oncol 23: 7697\u20137702","journal-title":"J Clin Oncol"},{"key":"BF6603951_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V85.2.307.307","volume":"85","author":"S O'Brien","year":"1995","unstructured":"O'Brien S, del Giglio A, Keating M (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85: 307\u2013318","journal-title":"Blood"},{"key":"BF6603951_CR32","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood.V89.8.2833","volume":"89","author":"LM Osorio","year":"1997","unstructured":"Osorio LM, De Santiago A, Aguilar-Santelises M, Mellstedt H, Jondal M (1997) CD6 ligation modulates the Bcl-2\/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 89: 2833\u20132841","journal-title":"Blood"},{"key":"BF6603951_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/10428199809092690","volume":"28","author":"C Pepper","year":"1998","unstructured":"Pepper C, Hoy T, Bentley P (1998) Elevated Bcl-2\/Bax are consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukemia and are correlated with in vivo chemoresistance. Leuk Lymphoma 28: 355\u2013361","journal-title":"Leuk Lymphoma"},{"key":"BF6603951_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219\u2013234","journal-title":"Blood"},{"key":"BF6603951_CR35","first-page":"456","volume":"10","author":"LE Robertson","year":"1996","unstructured":"Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456\u2013459","journal-title":"Leukemia"},{"key":"BF6603951_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ajh.2830040406","volume":"4","author":"RT Silver","year":"1978","unstructured":"Silver RT, Sawitsky A, Rai K, Holland JF, Glidewell O (1978) Guidelines for protocol studies in chronic lymphocytic leukemia. Am J Hematol 4: 343\u2013358","journal-title":"Am J Hematol"},{"key":"BF6603951_CR37","first-page":"1055","volume":"12","author":"A Thomas","year":"1996","unstructured":"Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2\/bax proteins in drug resistance. Oncogene 12: 1055\u20131062","journal-title":"Oncogene"},{"key":"BF6603951_CR38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1182\/blood.V99.6.2262","volume":"99","author":"G Tobin","year":"2002","unstructured":"Tobin G, Thunberg U, Johnson A, Thorn I, S\u00f6derberg O, Hultdin M, Botling J, Enblad G, S\u00e4llstr\u00f6m J, Sundstr\u00f6m C, Roos G, Rosenquist R (2002) Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 99: 2262\u20132264","journal-title":"Blood"},{"key":"BF6603951_CR39","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, David F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257\u20132317","journal-title":"Leukemia"},{"key":"BF6603951_CR40","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","volume":"19","author":"CY Wang","year":"1999","unstructured":"Wang CY, Guttridge DC, Mayo MW, Baldwin Jr AS (1999) NF-\u03baB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19: 5923\u20135929","journal-title":"Mol Cell Biol"},{"key":"BF6603951_CR41","doi-asserted-by":"publisher","first-page":"22781","DOI":"10.1074\/jbc.M201469200","volume":"277","author":"AB Werner","year":"2002","unstructured":"Werner AB, de Vries E, Tait SW, Bontjer I, Borst J (2002) Bcl-2 family member Bfl-1\/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J Biol Chem 277: 22781\u201322788","journal-title":"J Biol Chem"},{"key":"BF6603951_CR42","first-page":"63","volume":"96","author":"P Willems","year":"2000","unstructured":"Willems P, Verhagen O, Segeren C, Veenhuizen P, Guikema J, Wiemer E, Groothuis L, Buitenweg-de Jong T, Kok H, Bloem A, Bos N, Vellenga E, Mensink E, Sonneveld P, Lokhorst H, van der Schoot E, Raymakers R (2000) Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Blood 96: 63\u201370","journal-title":"Blood"},{"key":"BF6603951_CR43","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1101\/gad.1304105","volume":"19","author":"SN Willis","year":"2005","unstructured":"Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DCS (2005) Proapoptotic bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294\u20131305","journal-title":"Genes Dev"},{"key":"BF6603951_CR44","doi-asserted-by":"publisher","first-page":"11092","DOI":"10.1074\/jbc.275.15.11092","volume":"275","author":"H Zhang","year":"2000","unstructured":"Zhang H, Cowan-Jacob SW, Simonen M, Greenhalf W, Heim J, Meyhack B (2000) Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells. J Biol Chem 275: 11092\u201311099","journal-title":"J Biol Chem"},{"key":"BF6603951_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1101\/gad.13.4.382","volume":"13","author":"WX Zong","year":"1999","unstructured":"Zong WX, Edelstein LC, Chen C, Bash J, G\u00e9linas C (1999) The prosurvival Bcl-2 homolog Bfl-1\/A1 is a direct transcriptional target of NF\u03baB that blocks TNF\u03b1-induced apoptosis. Genes Dev 13: 382\u2013387","journal-title":"Genes Dev"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603951","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:28:48Z","timestamp":1684412928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,28]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF6603951"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603951","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,28]]}}}